FRI0445 Tildrakizumab Treatment Improved Measures of Psoriatic Arthritis in Adults with Chronic Plaque Psoriasis

R.G. Langley; D. Thaçi; K. Reich; K. Papp; A. Mehta; Q. Li; C. La Rosa

doi:10.1136/annrheumdis-2016-eular.3342

Article info

Poster Presentations

Psoriatic arthritis

FRI0445 Tildrakizumab Treatment Improved Measures of Psoriatic Arthritis in Adults with Chronic Plaque Psoriasis

Authors

R.G. Langley 1Dalhousie University, Halifax, Canada PubMed articles Google scholar articles
D. Thaçi 2University of Lübeck, Lübeck PubMed articles Google scholar articles
K. Reich 3SCIderm Research Institute and Dermatologikum Hamburg, Hamburg, Germany PubMed articles Google scholar articles
K. Papp 4Probity Medical Research, Waterloo, Canada PubMed articles Google scholar articles
A. Mehta 5Merck & Co., Inc., Kenilworth, United States PubMed articles Google scholar articles
Q. Li 5Merck & Co., Inc., Kenilworth, United States PubMed articles Google scholar articles
C. La Rosa 5Merck & Co., Inc., Kenilworth, United States PubMed articles Google scholar articles

Citation

Langley R, Thaçi D, Reich K, et al

FRI0445 Tildrakizumab Treatment Improved Measures of Psoriatic Arthritis in Adults with Chronic Plaque Psoriasis

Annals of the Rheumatic Diseases 2016;75:596-597.

Publication history

First published July 15, 2016.

Online issue publication

July 15, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password